Middle East & Africa Dermatological Drugs Market Size & Outlook
Middle East & Africa dermatological drugs market, 2018-2030 (US$M)
Related Markets
MEA dermatological drugs market highlights
- The MEA dermatological drugs market generated a revenue of USD 779.0 million in 2024.
- The market is expected to grow at a CAGR of 8.9% from 2025 to 2030.
- In terms of segment, psoriasis was the largest revenue generating therapy in 2024.
- Psoriasis is the most lucrative therapy segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 779.0 million |
| Market revenue in 2030 | USD 1,293.4 million |
| Growth rate | 8.9% (CAGR from 2025 to 2030) |
| Largest segment | Psoriasis |
| Fastest growing segment | Psoriasis |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Acne, Psoriasis, Rosacea, Alopecia |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.3% of the global dermatological drugs market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 11,428.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Dermatological Drugs Market Scope
Dermatological Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa dermatological drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dermatological drugs market will help companies and investors design strategic landscapes.
Psoriasis was the largest segment with a revenue share of 39.18% in 2024. Horizon Databook has segmented the Middle East & Africa dermatological drugs market based on acne, psoriasis, rosacea, alopecia covering the revenue growth of each sub-segment from 2018 to 2030.
The dermatological drugs market in the Middle East and Africa (MEA) is experiencing steady growth, driven by increasing demand for both therapeutic and aesthetic dermatology treatments. The market is expanding as a result of the rising prevalence of skin conditions such as acne, psoriasis, and eczema across the region.
Additionally, there is a growing focus on skincare and anti-aging treatments, contributing to the demand for dermatological products. Key drivers for market growth in the MEA region include increasing disposable income, improved access to healthcare services, and ongoing healthcare sector advancements.
The region's expanding healthcare infrastructure, coupled with a growing awareness of skin health, is further stimulating demand for dermatological drugs. Innovations in dermatology treatments, particularly the development of biologics are expected to continue to drive market growth during the forecast period.
Reasons to subscribe to Middle East & Africa dermatological drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa dermatological drugs market databook
-
Our clientele includes a mix of dermatological drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa dermatological drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa dermatological drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA dermatological drugs market size, by country, 2018-2030 (US$M)
Middle East & Africa Dermatological Drugs Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
